Published: 12/07/2020 12:26 GMT Chimerix Inc (CMRX) - Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir As a Medical Countermeasure for Smallpox.
Chimerix Inc - FDA Granted Priority Review and Set Action Date of April 7, 2021 Under PDUFA.